9847991|t|Clinical trials and therapy.
9847991|a|Parallel-group studies have established the efficacy of cholinesterase inhibitors in Alzheimer's disease, at least for short-term cognitive and clinical global enhancement. Noncognitive outcomes are currently under scrutiny. Time to reach clinical milestones may be a more useful trial design for new studies aiming to delay appearance or progression of disease.
9847991	114	133	Alzheimer's disease	Disease	MESH:D000544

